The primary end point was reached in all participants after a total follow-up of 6.1 years in the low-fat group and 8.1 years in the LCMD group ; median survival time was 2.8 years ( 95 % CI 2.4-3 .2 ) and 4.8 years ( 4.3-5 .2 ) , respectively .